Improving malaria surveillance using blood tests and genetic data
Improving the accuracy of malaria surveillance with serology and parasite genetic data
This study is looking to improve how we track malaria in places like Uganda by testing new ways to analyze blood samples and comparing two types of bednets to see which one works better at preventing malaria.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10987057 on NIH RePORTER |
What this research studies
This research aims to enhance malaria surveillance in high-burden areas like Uganda by using advanced techniques to analyze parasite DNA and antibodies in blood samples. By collecting data from 64 health facilities, the study will compare the effectiveness of two types of bednets in reducing malaria incidence. Cross-sectional surveys will be conducted at multiple time points to gather comprehensive data on malaria cases. The goal is to determine if molecular surveillance can provide more accurate estimates of malaria incidence than traditional methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 12 years old living in malaria-endemic areas of Uganda.
Not a fit: Patients who do not live in malaria-endemic regions or are over the age of 12 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective malaria control strategies and improved health outcomes for children in high-burden regions.
How similar studies have performed: Previous research has shown that molecular surveillance techniques can improve disease tracking and management, indicating a promising approach for malaria control.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Briggs, Jessica — University of California, San Francisco
- Study coordinator: Briggs, Jessica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.